Načítá se...
Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis
PURPOSE: Amifostine is a highly efficacious cytoprotectant when administered in vivo at high doses. However, at elevated doses, drug toxicity manifests for general, non-clinical radioprotective purposes. Various strategies have been developed to avoid toxic side-effects: The simplest is reducing the...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Informa Healthcare
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133974/ https://ncbi.nlm.nih.gov/pubmed/24597748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/09553002.2014.899450 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|